Acadia Pharmaceuticals (ACAD) Position Boosted by BlackRock Inc

ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders.The firm is valued at $2.06 billion. Boeing (BA), among the hardest-hit stocks on Wednesday after China retaliated with $50 billion in tariffs on USA goods, rose 2.74 percent, giving the Dow its biggest boost, followed by Goldman Sachs (GS), up 1.26 percent.

ACAD traded down $0.60 on Friday, reaching $21.53. About 1.13 million shares traded.

Acadia Pharmaceuticals (NASDAQ:ACAD) last released its earnings results on Tuesday, February 27th.

Ryan Heslop decreased its stake in Anthem Inc (ANTM) by 59.32% based on its latest 2017Q4 regulatory filing with the SEC. Handelsbanken Fonder AB now owns 210,000 shares of the biopharmaceutical company's stock worth $6,323,000 after buying an additional 20,000 shares in the last quarter. The hedge fund run by Ryan Heslop held 65,000 shares of the health care company at the end of 2017Q4, valued at $14.63 million, down from 159,800 at the end of the previous reported quarter.

The move comes after 7 months negative chart setup for the $2.06 billion company. The stock decreased 2.58% or $5.95 during the last trading session, reaching $224.78. After going under observation of traders 1.13 million shares traded at hands. Anthem, Inc. (NYSE:ANTM) has risen 35.30% since April 8, 2017 and is uptrending. Creative Planning owns 0.01% invested in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) to report earnings on May, 8.

More news: Tornado drills will take place across MI this week

Earnings forecasts have increased sharply since Congress approved sweeping changes to the US tax law late last year, with first-quarter earnings growth expected to be the highest in seven years. Steward Partners Investment Advisory LLC acquired a new position in Acadia Pharmaceuticals in the fourth quarter valued at approximately $200,000.

Since October 4, 2017, it had 1 buying transaction, and 3 insider sales for $3.94 million activity. ACADIA Pharmaceuticals Inc (NASDAQ: ACAD) is a stock with 128.26M shares outstanding. (NASDAQ:ACAD) was sold by Baity Glenn on Wednesday, October 4. The United Kingdom-based Pictet Asset Mngmt Ltd has invested 0.11% in ACADIA Pharmaceuticals Inc.

In other news, Director Daniel B. Soland purchased 7,000 shares of the business's stock in a transaction dated Thursday, March 1st.

Big Money Sentiment increased to 1.26 in Q4 2017. That's 0.25, from change from 2017Q3's 1.01. Sold All: 4 Reduced: 12 Increased: 18 New Position: 11. 65 increased positions while 32 funds acquired positions. 117.35 million shares or 3.35% more from 113.55 million shares in 2017Q3 were reported. Parametric Port Assocs Limited Liability holds 0% in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD). Bankshares Of Mellon invested in 456,482 shares. Prudential has invested 0.01% in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) for 1.19 million shs. Aqr Cap Mngmt Ltd Liability reported 36,563 shs. Price T Rowe Assocs Md reported 0% in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) for 12,273 shares. Federated Invsts Pa holds 0.01% in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) or 42,147 shares. $234,910 worth of ACADIA Pharmaceuticals Inc. Sei Investments Co. grew its holdings in ACADIA Pharmaceuticals by 15.1% in the 3rd quarter. (NASDAQ:CUI) for 114,041 shares. Therefore 75% are positive. ACADIA Pharmaceuticals had 33 analyst reports since August 7, 2015 according to SRatingsIntel. $1.53 million worth of ACADIA Pharmaceuticals Inc. The rating was reinitiated by Roth Capital on Wednesday, October 19 with "Neutral". The firm has "Buy" rating by Bank of America given on Tuesday, November 8. Leerink Swann initiated ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD). 31,160 are held by Tocqueville Asset Mgmt Lp. Ladenburg Thalmann has "Buy" rating and $48 target. The active investment managers in our database reported: 4.24 million shares, up from 2.03 million shares in 2017Q3. Acadia Pharmaceuticals now has a consensus rating of "Buy" and an average target price of $49.50. The stock has "Buy" rating by H.C. Wainwright on Wednesday, August 9. BB&T Securities LLC grew its holdings in shares of Acadia Pharmaceuticals by 136.0% during the fourth quarter. It also reduced its holding in Puma Biotechnology Inc (NYSE:PBYI) by 3,511 shares in the quarter, leaving it with 17,044 shares, and cut its stake in Wave Life Sciences Ltd. Two analysts have rated the stock with a sell rating, three have issued a hold rating and ten have given a buy rating to the stock. The rating was upgraded by Vetr to "Hold" on Monday, August 10. The firm has "Buy" rating by Jefferies given on Monday, September 4. Jefferies maintained it with "Buy" rating and $176 target in Friday, January 8 report. The rating was initiated by Bernstein on Thursday, June 16 with "Outperform".

Echostar Corporation-Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Like this



10 April 2018
$25M settlement finalized in Trump University lawsuit
After a federal appeals court rejected a student's objection to the settlement in February, Curiel finalized the deal on Monday. The settlement was reached shortly after Trump - whose statements on Curiel were widely condemned - was elected president.

10 April 2018
Mariners place Ryon Healy (ankle) on the disabled list
Healy also suffered a setback in mid-February when he underwent surgery to remove a bone spur from this right hand. Bradford, who the Mariners claimed this offseason from the Mets, made his Major League Baseball debut in 2017.

10 April 2018
Possible Norovirus Outbreak at BC Oyster Farms
Shellfish Growers Association noted that while only two farms were closed, the entire industry will likely be hit by the impact. Consumers should also report oyster-related illnesses to their local health authority for investigation and follow-up.

10 April 2018
Sleep Deprivation Associated with Development of Alzheimer's Disease
Participants in this case were closely monitored, and were also asked how many hours of sleep they got on average. While small, it was the first of its kind to use human beings in a controlled setting.

10 April 2018
U.S. deficit, debt to balloon under Trump tax cuts: Congressional Budget Office
CBO stated that, "Such high and rising debt would have serious negative consequences for the budget and the nation". It said that while the measures will temporarily boost the U.S. economy, they will exacerbate its long-term debt.

10 April 2018
Protecting your information in the wake of Facebook's massive data breach
Bill Nelson, Florida Democrat, told MSNBC that the Federal Communications Commission should be involved in Facebook regulation. Nelson and Senate Commerce Committee Chairman John Thune asked Zuckerberg to testify to "restore lost trust" in the company.

10 April 2018
Police arrest 3 accused in Bywater, Uptown armed robberies
They tried to stop Huerta, but he eluded police, driving up to 50 miles per hour on Utah, Arizona and Park Streets, police said. After fleeing the scene, the vehicle was later located near the intersection of 26th Street and Benning Road.

10 April 2018
Genworth Financial (GNW) Receives Daily News Sentiment Rating of 0.19
The financial services provider reported $0.65 EPS for the quarter, topping analysts' consensus estimates of $0.20 by $0.45. ValuEngine cut shares of Genworth Financial from a "buy" rating to a "hold" rating in a report on Thursday, March 1st.

10 April 2018
Iran's rial at All times low against the Buck
This year's ceremony comes after the International Atomic Energy Agency (IAEA) in February reaffirmed Iran's commitment to the JCPOA for the tenth time.

10 April 2018
PBF Energy Inc. (PBF) Lowered to Sell by Zacks Investment Research
Zacks Investment Research cut PBF Energy from a "buy" rating to a "hold" rating in a research report on Tuesday, December 19th. As per Thursday, July 20, the company rating was maintained by RBC Capital Markets. (NYSE:PBF) rating on Wednesday, June 29.